INJ Price Holds $12.98 Despite Exchange Delistings and Regulatory Headwinds
Joerg Hiller Sep 01, 2025 08:22
Injective (INJ) trades at $12.98 with neutral RSI at 45.79 as regulatory pressures trigger exchange delistings, creating mixed technical signals for traders.
Quick Take
• INJ currently trading at $12.98 (+0.08% in 24h) • Injective's RSI at 45.79 indicates neutral momentum amid regulatory uncertainty • Exchange delistings drive 22.22% weekly decline as compliance issues mount
What's Driving Injective Price Today?
The INJ price has stabilized around $12.97-$12.98 following a turbulent week marked by significant regulatory challenges. The most impactful development occurred on August 27, when Injective experienced a sharp 22.22% decline in a single day due to mounting regulatory scrutiny and compliance concerns.
Major cryptocurrency exchanges have begun delisting INJ tokens over regulatory compliance issues, creating immediate selling pressure and raising questions about the protocol's operational stability. The delistings were accompanied by reports of staff layoffs and paused product development, signaling deeper organizational challenges beyond just regulatory pressure.
Most recently, on August 31, the INJ price dropped to $12.97 as these regulatory pressures continued to weigh on investor sentiment. The regulatory uncertainty has created a cautious market environment where traders are closely monitoring for any updates on compliance resolutions or further exchange actions.
Despite these challenges, the current INJ price action shows some stabilization, with today's modest 0.08% gain suggesting that the immediate panic selling may have subsided. However, the 24-hour trading volume of $10.1 million on Binance spot market indicates relatively muted interest compared to previous weeks.
INJ Technical Analysis: Neutral Signals Emerge Amid Bearish Backdrop
The current Injective technical analysis reveals a complex picture with mixed signals across different timeframes. Injective's RSI sits at 45.79, placing it firmly in neutral territory and suggesting that neither bulls nor bears have decisive control at current levels.
The INJ RSI reading below 50 indicates some bearish undertone, but the indicator hasn't reached oversold levels below 30, suggesting there may be room for further downside if selling pressure intensifies. This neutral RSI positioning often precedes either a consolidation phase or a breakout in either direction.
Injective's MACD indicator shows clearly bearish momentum with a reading of -0.2485 and a histogram of -0.1727. This divergence between the neutral RSI and bearish MACD suggests that while immediate selling pressure has eased, the underlying trend remains downward-biased.
The Stochastic indicators paint an even more bearish picture, with the %K at 21.71 and %D at 10.04, both well into oversold territory. This could indicate that Injective is approaching a potential bounce zone, though oversold conditions can persist during strong downtrends.
From a moving average perspective, the INJ price at $12.98 sits below most short and medium-term averages, with Injective's SMA 7 at $13.20 and SMA 20 at $13.98 acting as immediate resistance levels. However, the price remains above the 200-day SMA at $11.83, which could provide longer-term support.
Injective Price Levels: Key Support and Resistance
Based on current market structure, several critical Injective support levels have emerged that traders should monitor closely. The immediate INJ resistance level sits at $16.55, which aligns with both technical resistance and the strong resistance zone identified in the analysis.
On the downside, Injective support levels are clustered around current price action. The immediate support at $12.37 represents the 24-hour low and serves as the first line of defense for bulls. A break below this level could accelerate selling toward the stronger support zone at $11.91.
The Bollinger Bands provide additional context for INJ resistance and support levels. With the upper band at $15.90 and lower band at $12.06, the current price sits near the lower portion of the range, suggesting limited downside before reaching the lower band support.
The pivot point analysis indicates $12.80 as a key level for intraday trading in the INJ/USDT pair. Holding above this level could signal short-term stability, while a break below might trigger further selling pressure toward the $11.91 support zone.
Traders should also note that the Average True Range (ATR) of $1.08 suggests relatively high volatility, meaning these support and resistance levels could be tested quickly in either direction.
Should You Buy INJ Now? Risk-Reward Analysis
The current risk-reward profile for INJ presents a challenging decision for different types of traders. Based on Binance spot market data and recent price action, several scenarios emerge depending on trading timeframe and risk tolerance.
For short-term traders, the neutral INJ RSI and oversold Stochastic readings suggest a potential bounce could occur from current levels. However, the bearish MACD and recent regulatory headwinds create significant downside risk. A conservative approach would be to wait for a clear break above $13.20 (SMA 7) before considering long positions.
Swing traders might find opportunity in the current INJ price compression between $12.37 support and $13.20 resistance. The key risk level sits at $11.91, representing roughly 8% downside from current levels. This provides a clear stop-loss level for those willing to bet on a regulatory resolution bounce.
Long-term investors face the most uncertainty, as the regulatory challenges could persist for months. The fact that major exchanges have delisted INJ suggests fundamental issues that extend beyond technical analysis. Until regulatory clarity emerges, accumulation strategies carry significant regulatory risk.
The most prudent approach appears to be waiting for either a break above $15.90 (upper Bollinger Band) to signal regulatory resolution, or a test of the $11.83 level (200-day SMA) for potential value entry with strict risk management.
Conclusion
The INJ price action over the next 24-48 hours will likely depend more on regulatory developments than technical factors. While Injective technical analysis shows neutral momentum that could support a short-term bounce, the fundamental challenges from exchange delistings create ongoing headwinds. Traders should monitor the $12.37 support level closely, as a break below could accelerate selling toward $11.91. Conversely, any positive regulatory news could trigger a swift recovery toward the $15.90 resistance zone.
Image source: Shutterstock.jpg)